Company registration number: 15302798
Unaudited financial statements
for the period ended 30 November 2024
for
Founders Health Holding Ltd
Pages for filing with the Registrar
Company registration number: 15302798
Founders Health Holding Ltd
Balance sheet
as at 30 November 2024
Note £ £
Fixed assets
Tangible assets 4 653
653
Current assets
Debtors 40,130
Cash at bank and in hand 981,971
1,022,101
Creditors: amounts falling due within one
year
(176,236)
Net current assets 845,865
Total assets less current liabilities 846,518
NET ASSETS 846,518
Capital and reserves
Called up share capital 1
Other reserves 1,049,989
Profit and loss account (203,472)
TOTAL EQUITY 846,518
The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the period ended 30 November 2024.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The directors acknowledge their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.
1
Company registration number: 15302798
Founders Health Holding Ltd
Balance sheet - continued
as at 30 November 2024
The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.
These financial statements were approved by the Board of directors and authorised for issue on 19 August 2025 and signed on its behalf by:
Ms C Dawson, Director
19 August 2025
2
Founders Health Holding Ltd
Notes to the financial statements
for the period ended 30 November 2024
1 Company information
Founders Health Holding Ltd is a private company registered in England and Wales. Its registered number is 15302798. The company is limited by shares. Its registered office is 180 Strand, 2 Arundel Street, London, WC2R 3DA.
2 Accounting policies
Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.
Going concern
In preparing these financial statements, the directors have assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company's ability to continue as a going concern. In making this assessment, the directors take into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.
The directors consider that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.
Exemption from preparation of consolidated financial statements
The financial statements contain information about Founders Health Holding Ltd as an individual company and do not contain consolidated financial information as the parent of a group. The company is exempt under section 399(2A) of the Companies Act 2006 from the requirements to prepare consolidated financial statements.
Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery etc.:
Computer Equipment - 33.33% straight line
Retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit and loss in the period to which they relate.
3 Average number of employees
During the period the average number of employees was 1.
3
Founders Health Holding Ltd
Notes to the financial statements - continued
for the period ended 30 November 2024
4 Tangible fixed assets
Plant and
machinery
etc.
£
Cost
At 30 November 2024 839
Depreciation
Charge for period 186
At 30 November 2024 186
Net book value
At 30 November 2024 653
5 Advances, credit and guarantees granted to directors
There were no advances, credits and guarantees granted to the directors during the period.
6 Guarantees and other financial commitments
There were no financial guarantees or commitments, either ongoing or entered into during the period.
7 Off-balance sheet arrangements
The company had no off-balance sheet arrangements at year-end or at any stage during the period.
8 Post balance sheet events
On 16 December 2024, after the reporting period, the company entered into a share-for-share exchange with Tempus Intl Limited. As part of this arrangement, no cash consideration was involved, and shares were issued to the shareholders of Tempus Intl Limited in exchange for 50% of the company's issued shares. The transaction did not impact the financial position as at 30 November 2024.
9 Interests in Joint Ventures
The company entered into two joint venture arrangements during the year, establishing Founder Longevity Limited and Forgevity Limited. These joint ventures intended to explore strategic collaborations; however, no trading activity occurred in either entity, and no capital consideration was exchanged. Both joint ventures remain dormant and are currently in the process of being wound down.

There was no financial activity during the year; no material assets or liabilities were held. Therefore, both joint ventures have been excluded from consolidation. The directors consider the impact of these joint ventures to be immaterial to the financial statements.
4
Founders Health Holding Ltd
Notes to the financial statements - continued
for the period ended 30 November 2024
10 Controlling party
The immediate and ultimate controlling party is Founders Forum LLP a limited liability partnership incorporated in England and Wales, which holds 100 % of the issued share capital of the company.
5